Leukemia. Plasma cell leukemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Willingness of the client to participate in the research Having access to a mobile phone with Android operating system Be able to read and write and to work with a mobile phone The client should be only undergoing chemotherapy and has not received other methods such as bone marrow transplant The client should have completed a maximum of three chemotherapy courses
Exclusion criteria
Exclusion criteria: The client's unwillingness to continue cooperation in each of the stages of the study It becomes impossible for the client to use the educational application for any reason The patient's chemotherapy course has been stopped Patient's death
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Fatigue. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Nausea. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Depression. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Anxiety. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Drowsiness. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Appetite. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Feeling of Well-Being. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale.;Shortness of Breath. Timepoint: Before and six weeks after the intervention. Method of measurement: Edmonton Symptom Assessment Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences